91
Participants
Start Date
September 17, 2014
Primary Completion Date
August 22, 2017
Study Completion Date
August 22, 2017
cAd3-EBO Z at 1 x 10^10 vp
Low dose cAd3-EBO Z
cAd3-EBO Z at 2.5 x 10^10 vp
Medium dose cAd3-EBO Z
cAd3-EBO Z at 5 x 10^10 vp
High dose cAd3-EBO Z
4.4x10^8 TCID50s MVA-BN® Filo
High dose MVA-BN® Filo
2.2x10^8 TCID50s MVA-BN® Filo
Low dose MVA-BN® Filo
4.4 x 10^7 TCID50s MVA-BN® Filo
Very low dose MVA-BN® Filo
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford
Wellcome Trust
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Oxford
OTHER